Canada markets closed

Sigyn Therapeutics, Inc. (SIGY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
5.25+0.25 (+5.00%)
At close: 12:27PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 6.43M
Enterprise Value 9.05M
Trailing P/E 0.27
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)39.04
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -2.10

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 315.13%
S&P500 52-Week Change 328.04%
52 Week High 312.80
52 Week Low 30.15
50-Day Moving Average 35.37
200-Day Moving Average 36.77

Share Statistics

Avg Vol (3 month) 3103
Avg Vol (10 day) 390
Shares Outstanding 51.22M
Implied Shares Outstanding 61.22M
Float 8455.32k
% Held by Insiders 153.59%
% Held by Institutions 17.60%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Aug 10, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:40
Last Split Date 3Jan 31, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-325.80%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -2.56M
Net Income Avi to Common (ttm)-3.56M
Diluted EPS (ttm)-3.00
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)32.84k
Total Cash Per Share (mrq)0.03
Total Debt (mrq)2.65M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.03
Book Value Per Share (mrq)-3.28

Cash Flow Statement

Operating Cash Flow (ttm)-1.06M
Levered Free Cash Flow (ttm)495.08k